View Older Stories View More Recent Stories
-
Newmont Announces Pricing of Debt Tender Offer
-
BMO Capital Starts bluebird bio (BLUE) at Market Perform
-
BMO Capital Starts Alder Biopharm (ALDR) at Outperform
-
Vantiv (VNTV) to Acquire Moneris USA for $425M
-
Vantiv Announces Agreement to Acquire Moneris Solutions USA
-
Jazz Pharmaceuticals Announces Participation in Three Upcoming Investor Conferences
-
AMSURG Corp. Announces Launch of Tender Offer and Consent Solicitation for Its 5.625% Senior Notes Due 2020
-
Notable Analyst Rating Changes 11/10: (HUM) (IBM) (WFT) Upgraded; (AXL) (BEN) (VTR) Downgraded
-
BMO Capital Markets Introduces Environmental, Social & Governance-Linked Principal Protected Deposit Notes
-
MEDIA ADVISORY: Celebrate the Next Generation of Canadian Artists at the Fourteenth Annual BMO 1st Art! Exhibition
-
Newmont Announces Early Tender Results of Debt Tender Offer
-
BMO Capital Cuts Price Target on TubeMogul (TUBE) to $8 Following 3Q Report
-
BMO Capital Downgrades Ventas (VTR) to Underperform
-
BMO Capital Downgrades Arctic Cat (ACAT) to Underperform
-
BMO Capital Downgrades CSX (CSX) to Market Perform
-
BMO Capital Downgrades Hecla Mining (HL) to Underperform
-
Today's Biotech Upside Could Be Just the Start - BMO Capital (IBB) (XBI)
-
Complete Donald Trump Stock Impact Guide
-
Bond investors price for inflation, uncertainty after Trump victory
-
Prices fall as Trump election win fuels inflation bets
-
BMO Capital Cuts Price Target on Jazz Pharmaceuticals (JAZZ) to $192
-
BMO Capital Upgrades Randgold Resources Ltd. (GOLD) to Outperform
-
BMO Capital Raises Price Target on Kennametal (KMT) Following Analyst Day
-
Major Pharma Got a Major Win Last Night - BMO
-
MEDIA ADVISORY / INTERVIEW OPPORTUNITY: BMO Experts Available for Market Commentary After U.S. Election
-
Sysco Corp. (SYY): Raising PT to $56 - BMO
-
Form 13F-NT BMO CAPITAL MARKETS CORP For: Sep 30
-
Valeant (VRX) Q3 a Mixed Bag, Guidance Cut on Higher Side of Expectations - BMO
-
Abbvie (ABBV) PTAB Decision Incrementally Positive, But Does Not Change Cautious Thesis - BMO
-
Streetinsider.com's Hot Lunchtime Reads 11/7: (WATT) (ACIA) (LC) (IONS)
-
Projects & Money 2017 Registration is Now Open
-
Ionis Pharmaceuticals (IONS) Bullish View Reiterated at BMO Capital Following Spinraza Update
-
BMO Asset Management Announces Proposed Termination of a BMO Exchange Traded Fund
-
Notable Analyst Rating Changes 11/4: (ACHN) (MMC) (HCP) Upgraded; (AXL) (BRO) (WFM) Downgraded
-
MEDIA ADVISORY / INTERVIEW OPPORTUNITY: BMO Experts Available for Market Commentary After U.S. Election
-
Retrophin (RTRX): DUET Data At ASN Could Preview FDA - BMO
-
BMO Capital Downgrades Brown & Brown (BRO) to Underperform Amid Slow EPS Growth
-
BMO Capital Upgrades Marsh & McLennan (MMC) to Outperform; Pullback Creates Buying Chance
-
BMO Capital Downgrades MDC Partners (MDCA) to Market Perform, PT Slashed to $5
-
BMO Capital Cuts Price Target on Qualcomm (QCOM) to $67 Following 4Q
-
Facebook (FB) PT Lowered to $125 at BMO Capital
-
Whole Foods Market (WFM): Mixed Signals Drive Estimate Cuts - BMO
-
UPDATE: BMO Capital Maintains Gilead Sciences (GILD) at Market Perform (Correction)
-
BMO Capital Starts Party City (PRTY) at Market Perform
-
BMO Capital Downgrades Pfizer (PFE) to Market Perform
-
BMO Capital Upgrades Glatfelter (GLT) to Outperform
-
AveXis (AVXS) PT Raised to $80 at BMO Capital Following AVXS-101 Update
-
BMO Capital Downgrades Pfizer (PFE) to Market Perform
-
TransCanada Provides Update on Strategic Initiatives
-
Regulus Reports Third Quarter 2016 Financial Results

